NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/25/2024
Back to search
Official data from USPTO
VASTRAX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
09/25/2024
Trademark type
Combined
Nice classes
35, 42
Filing date
09/18/2017
Registration date
04/17/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/25/2024
Last transaction
09/25/2024
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
06/30/2016
First use in commerce
06/30/2016
Drawing code
3
Owner type
03
Owner location
ANDOVER, MA
Examiner
MICKLEBURGH, LINDA BOHANNON
Current location
FILE DESTROYED
Mark description
The mark consists of the word "VASTRAX" with two wavy lines above the letters "VAS".
Holders and representatives
Holders
VASTRAX, INC.
Ora, Inc.
Representatives
Michael R Rizzo SAUNDERS & SILVERSTEIN LLP
Technical classification
Nice Classes
Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
business consulting services; marketing consulting services; business strategy consulting services; business consulting and management in the field of clinical trialsclinical data and regulatory submission management on behalf of medicalbiopharmaceutical and biotechnology companies to assist them with clinical researchclinical trials and applications for drug and medical device approval; compilation and analysis of biostatistics for business or commercial purposes ; business development services; advertising consulting services; public relations
Class 42
medical and scientific researchdesigning clinical trialsdeveloping regulatory strategiesproduct development strategiesconducting clinical trials; pharmaceutical drug and medical device development services; pharmaceutical and medical device testing services; designing and conducting clinical trials for others related to pharmaceutical drugs and medical devices; medical device development services for others
Publications
History of USPTO decisions and trademark events.
15 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/25/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/25/2024
E815
TEAS SECTION 8 & 15 RECEIVED
03/21/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
04/17/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
05/11/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
04/17/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/30/2018
PUBO
PUBLISHED FOR OPPOSITION
01/30/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/10/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/21/2017
DOCK
ASSIGNED TO EXAMINER
12/21/2017
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
09/23/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/22/2017
NWAP
NEW APPLICATION ENTERED
09/21/2017
Continuous trademark protection
Get notified about every new filing that threatens VASTRAX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.